You are here
AdvaMedDx held a briefing on Capitol Hill on March 3, 2016.
New and potentially dangerous infectious diseases e... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN) to host a series of state-based personalized medicine roundtable events in order to bring attention to the role... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN) to host a series of state-based personalized medicine roundtable events in order to bring attention to the role... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN) to host a series of state-based personalized medicine roundtable events in order to bring attention to the role... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN) to host a series of state-based personalized medicine roundtable events in order to bring attention to the role... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN) to host a series of state-based personalized medicine roundtable events in order to bring attention to the role... more
AdvaMedDx partnered with the American Association for Cancer Research (AACR) for a briefing on Capitol Hill on June 8, 2015... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN), the Association of Community Cance... more
AdvaMedDx, the European Diagnostics Manufacturers Association (EDMA), and the Global Medical Technology Alliance (GMTA) hel... more
AdvaMedDx Executive Director Andrew Fish testified before the U.S. House of Representatives Energy and Commerce Committee in support of FDA taking a risk-based approach to the regulation of lab-dev... more